Low-Intensity Ultrasound for Breaking Down Long COVID Microclots
Research suggests that low-intensity ultrasound may be a promising noninvasive method for breaking down microclots in long COVID patients.
Openwater has developed a low-intensity focused ultrasound device, Open-LIFU, which delivers the same ultrasound technology used in the microclots study and is available for clinical research into other disease applications.
Amyloid fibrinogen microclots, linked to long COVID, have also been identified in other chronic inflammatory conditions, causing blockage of blood flow, limited oxygen, and triggering inflammation.
Low-intensity ultrasound may provide a promising noninvasive way to break these microclots apart, laying the groundwork for future clinical studies.
This breakthrough could potentially lead to new treatments for long COVID and other conditions involving microclots.
Author's summary: Low-intensity ultrasound shows promise for treating long COVID microclots.